1Gray N S, Wodicka L, Thunnissen A M, et al. Drug target validation and indentification of secondary drug target effects using DNA microarrays. Nature medicine, 1998,(4):1293.
2Wang Y X, Rea T, Bian Junhuia, et al. Identification of the genes responsive to etoposide-induced apoptosis, application of DNA chip technology, FEBS Letters, 1999,445:269.
3Macbeath G, Schreiber S L. Pringting protein as microarray for high-throughput function determination. Science, 2000,289:1760.
4Tanaka H. Isolation od cDNAs encoding cellular drug-binding proteins using a novel expression cloning procedure: drug-western. Mol Pharmacol, 1999,50:356.
5Knopfe1 T, Kuhn R, Al1geier H. Metabotropic g1utamate receptors:novel targets for drug development. J Med Chem, 1995,38(9):1417.
6Keyt B A, Nguyen H V, Berleau L T, et al. Indentification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors gerneration of receptor-selective VEGF variants by site-directed mutagensis. J Biol Chem, 1996,271(10):5638.
7Salida Mirzoeva, Tanuja Koppal, Tatiana V, et al. Screening in a cell-based assay for inhibitors of microglial nitric oxide production reveals calmodulin-regulated rotein kinases as potential drug discovery targets. Brain Research, 1999,844:126.
8Marc Vidal, Hideki Endoh. Prospects for drug screening using the reverse two-hybrid system. Trends in biotechnology, 1999,17(9):374.
9Young K, Lin S, Sun L, et al. Identification of a calcium channel modulator using a high throughput yeast twohybrid screen. Nat Biotechnol, 1998,16(10):946.
10Sche P, Mchenzie K M, White J D, et al. Display cloning: functional identification of natural products using cDNA-phage display. Chem Biol, 1999,(5):707.
